Genprex to Present and Participate at Upcoming May Investor and Industry Conferences [Yahoo! Finance]
Genprex, Inc. (GNPX)
Last genprex, inc. earnings: 11/14 12:08 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
on developing life-changing therapies for patients with cancer and diabetes, today announced the Company's participation in the following upcoming investor and industry conferences to be held in May 2024 Event: Sidoti Microcap Conference Conference Dates May 8-9, 2024 Presentation Date Wednesday, May 8, 2024 Presentation Time 3:15 p.m. ET Venue: Virtual Presenter Ryan Confer , Genprex's Chief Financial Officer Presentation link https://bit.ly/3UlTsgl Mr. Confer will deliver an overview of the Company's pioneering gene therapies for cancer and diabetes and will be available for virtual meetings with investors through the conference platform. An archive of Mr. Confer's presentation will be available in the Investor Relations section of the Company's website. Event: American Society of Gene & Cell Therapy Annual Meeting Dates: May 7-11, 2024 Location: Baltimore Convention Center Company Participant: Thomas Gallagher, Senior Vice President of Intellectual Propert
Show less
Read more
Impact Snapshot
Event Time:
GNPX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GNPX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GNPX alerts
High impacting Genprex, Inc. news events
Weekly update
A roundup of the hottest topics
GNPX
News
- Genprex, Inc. (NASDAQ: GNPX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.MarketBeat
- Genprex dosing subjects in trial of combination therapy for small-cell lung cancer [Yahoo! Finance]Yahoo! Finance
- Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa® Immunogene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer [Yahoo! Finance]Yahoo! Finance
- Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa® Immunogene Therapy in Combination with Tecentriq® to Treat Small Cell Lung CancerPR Newswire
- Genprex Announces the Appointment of Jose A. Moreno Toscano as Chairman of the Board of Directors [Yahoo! Finance]Yahoo! Finance
GNPX
Earnings
- 8/21/23 - Miss
GNPX
Sec Filings
- 5/9/24 - Form 8-K
- 4/29/24 - Form ARS
- 4/29/24 - Form DEFA14A
- GNPX's page on the SEC website